<DOC>
	<DOCNO>NCT02247596</DOCNO>
	<brief_summary>The primary aim study examine effect two week oral resveratrol rest energy expenditure insulin sensitivity non-diabetic obese male subject . Secondary variable include plasma lipid subfraction , blood pressure glycated hemoglobin ( HbA1c ) .</brief_summary>
	<brief_title>Effects High-Dose Resveratrol Non-Diabetic Obese Males</brief_title>
	<detailed_description>Patients recruit July 2009 July 2012 single hospital Singapore . Eligible patient Chinese male , age 21 55 year old , body mass index ( BMI ) 30 kg/m2 venous glucose &lt; 7.0 &lt; 11.1 mmol/L 0 120 minute respectively oral glucose tolerance testing ( OGTT ) follow 12-hour fast . They must willing abstain embark exercise regime ingest large quantity resveratrol-containing food include alcohol study period . The study randomize , double-blind , parallel group trial consist screen visit , two-week treatment period post-treatment visit . Randomization centrally perform treatment assignment 2-digit reference code place seal opaque envelope maintain person responsible preparation intervention drug placebo . Trans-resveratrol extract Polygonum Cuspidatum ( Mega Resveratrol , Danbury , USA ) use trial . The placebo distinguishable color , form , taste active drug . The randomization code unblinded predefined data record . Subjects give 1g three time day either resveratrol placebo two week instruct abstain food high resveratrol content entire duration trial . Compliance determine pill count end trial period . Subjects arm allow commence exercise regimen supplement study period . Subjects drop trial would replace . All variable measure baseline end treatment period . RMR measure indirect calorimetry use breath-by-breath metabolic gas analyser via face-mask method . The investigator estimate sample size 18 patient per group ( Total N = 36 ) need provide 80 % power two-sided 5 % detect difference Cohen 's effect size 1.0 two group . All analysis perform use SPSS 21.0 ( IBM ) statistical significance set p &lt; 0.05 percentage change baseline unit analysis . All data analyze accord intention-to-treat principle . MANOVA perform compare intervention placebo group unadjusted adjust p-values study variable interest . Normal distribution verify Kolmogorov-Smirnov test data present mean Â± standard deviation ( SD ) .</detailed_description>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Ability give inform consent Obese Chinese Male Age 21 55 yr old No diabetes mellitus BMI 30 kg/m2 screen Unwilling abstain ingest large quantity resveratrolcontaining food ( eg . red wine , nut ) Cancer diagnosis currently treatment , clinically detectable , treat within past 5 year Terminal disease palliative care Current excessive alcohol intake ( &gt; 21 unit per week men ; 14 unit per week woman ) Known diabetes mellitus Past history unexplained hypoglycemia Past current history stroke History grape allergy On alternative traditional medication Treated another investigational drug within last 6 month Poorly control hypertension ( SBP &gt; /= 160 DBP &gt; /= 100 ) within last one month ALT and/or AST &gt; 1.5 time upper limit normal within last 6 month GFR &lt; 50 ml/min/1.73m2 ( MDRD equation ) within last 6 month Staff Department Medicine , Khoo Teck Puat Hospital</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Resveratrol</keyword>
	<keyword>obesity</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>energy expenditure</keyword>
	<keyword>diabetes</keyword>
</DOC>